Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

Nanoviricides reports progress on anti-COVID drugs

Nanoviricides reports that its two COVID-19 drug candidates have been “highly effective” against the virus in pre-clinical laboratory studies. The Shelton-based company is preparing a pre-IND...

| By Kelley Gipson

Rallybio funding fuels rare disease search

Rallybio is coming off an active year in 2020, when it moved its home office to New Haven’s Gold Building at 234 Church St., and...

| By Kelley Gipson

Yale COVID saliva test reaches 100 labs

SalivaDirect™ is an innovative and cost-effective saliva-based COVID-19 test developed by a team led by Wyllie and Nathan Grubaugh, an assistant professor at Yale School of Public...

| By Kelley Gipson

BioPath promotes local learning opportunities

The BioPath internship program is a now partnership between Southern Connecticut State University, Albertus Magnus College, Gateway Community College, the University of New Haven, and...

| By Kelley Gipson

Cybrexa and NCI to develop tumor-targeting drug

New Haven oncology biotech Cybrexa Therapeutics has agreed to work with the National Cancer Institute (NCI) on developing Cybrexa’s tumor-targeting drug, CBX-12. Under terms of...

| By Kelley Gipson

Farmington startup develops 3D bone implants

3D-printed bone implants are being developed by A.D.A.M., a Farmington-based startup. The company, which operates out of office and lab space inside UConn’s Technology Incubation...

| By Kelley Gipson

Vanessa Research supported Rare Disease Day 2021

Vanessa Research (VR) supported Rare Disease Day for the fourth consecutive year last week. Rare Disease Day is observed internationally each year on the last...

| By Kelley Gipson

Yale research fuels biotech advances

Intravenous injection of bone marrow derived stem cells in patients with spinal cord injuries led to significant improvement in motor functions, researchers from Yale University...